Pharma GMP News of the Week August 14, 2022

Pharma GMP News of the Week: 14-August-2022

Period: August 7, 2022 to August 13. 2022

News from TGA – TGA is inviting applications from professionals with adequate expertise in science, medicine, or consumer perspectives and issues.

Month of news: August  2022

The chosen applicants will give independent expert advice on technical matters relating to the r medical devices, regulation of medicines, vaccines and other products/ substances.

These members will provide advice throughout the therapeutic product life cycle, from pre-market evaluation to post market product safety. 

Source: https://www.tga.gov.au/vacancies-statutory-advisory-committees 

Public consultation on TGA’s proposal for changes to the Permissible Ingredients Determination – Low-negligible risk

Month of news: August  2022

The chosen applicants will give independent expert advice on technical matters relating to the r medical devices, regulation of medicines, vaccines and other products/ substances.

These members will provide advice throughout the therapeutic product life cycle, from pre-market evaluation to post market product safety. 

Source: https://www.tga.gov.au/consultation/consultation-2022-2023-proposed-changes-permissible-ingredients-determination-low-negligible-risk 

National Pharmaceutical Pricing Authority (NPPA, India) again extends price controls on medical devices

NPPA has proposed extending the price controls on identified medical devices from 31 July 2022 to 31 December 2022.

Source: https://www.nppaindia.nic.in/wp-content/uploads/2022/08/Gazett-Notification.pdf 

Scroll to Top